REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 28 filers reported holding REGULUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $34,000 | +100.0% | 114,440 | +106.9% | 0.00% | – |
Q4 2021 | $17,000 | -99.0% | 55,306 | -94.8% | 0.00% | -100.0% |
Q1 2021 | $1,670,000 | +4075.0% | 1,070,209 | +3501.5% | 0.00% | – |
Q4 2020 | $40,000 | +263.6% | 29,716 | +81.9% | 0.00% | – |
Q2 2020 | $11,000 | -47.6% | 16,332 | -26.5% | 0.00% | – |
Q4 2018 | $21,000 | – | 22,216 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,851,851 | $1,333,000 | 0.17% |
BVF INC/IL | 2,035,695 | $1,466,000 | 0.15% |
NEA Management Company, LLC | 2,052,455 | $1,478,000 | 0.12% |
EcoR1 Capital, LLC | 1,049,088 | $755,000 | 0.10% |
WEDBUSH SECURITIES INC | 41,167 | $30,000 | 0.00% |
West Oak Capital, LLC | 1,000 | $1,000 | 0.00% |
Virtu Financial LLC | 16,897 | $12,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 64,347 | $46,000 | 0.00% |
MORGAN STANLEY | 103 | $0 | 0.00% |
BLAIR WILLIAM & CO/IL | 10,200 | $7,000 | 0.00% |